NCT04680247 is a NA clinical trial of VA-LCP in Tibia Plateau Fracture, sponsored by Technical University of Munich.

Who is sponsoring NCT04680247?

NCT04680247 is sponsored by Technical University of Munich.

What drugs are being tested in NCT04680247?

Interventions in NCT04680247: VA-LCP, NCB-PT.

What condition does NCT04680247 study?

NCT04680247 studies Tibia Plateau Fracture.

Is NCT04680247 still recruiting?

NCT04680247 is currently completed. Last updated 22 December 2020.

Last reviewed 2020-12-22 · How we verify

NCT04680247

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Polyaxial Locking Plate Osteosynthesis in Proximal Tibia Fractures

Completed NA Last updated 22 December 2020

What this trial tests

NA trial testing VA-LCP in Tibia Plateau Fracture in 28 participants. Completed in 1 January 2017.

Timeline

5 October 2013

Primary endpoint
14 December 2016

1 January 2017

Quick facts

Lead sponsor	Technical University of Munich
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	28
Start date	5 October 2013
Primary completion	14 December 2016
Estimated completion	1 January 2017

Drugs / interventions tested

VA-LCP
NCB-PT

Conditions studied

Tibia Plateau Fracture — all drugs for Tibia Plateau Fracture →

Sponsor

Technical University of Munich

Who can join

Adults 18 to 95, any sex, with Tibia Plateau Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

From October 2013 28 patients with proximal tibia fractures (AO/ASIF 41 B-C) were included in this study. According to our treatment algorithm for this entity Patients were assigned into two groups and treated with different polyaxial locking plates (NCB-PT®, Zimmer vs. VA-LCP® Synthes). After 12 months postoperative the investigators conducted clinical and radiological follow-ups.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Outcome after polyaxial locking plate osteosynthesis in proximal tibia fractures: a prospective clinical trial.
Völk D, Neumaier M, Einhellig H, Biberthaler P, et al · · 2021 · cited 1× · PMID 33736638 · DOI 10.1186/s12891-021-04158-z

Verify or expand the search:

Other Technical University of Munich trials

Trials by the same sponsor.

NCT07519811 — LLM-Generated Plain-Language Patient Synopses to Improve Comprehension in Hematology and Oncology (oncOPAL) · NA · recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting
NCT07077005 — Mavacamten Enables Exercise in Hypertrophic Obstructive Cardiomyopathy · NA · recruiting
NCT07212699 — Development of an Outcome Score for Patients With Knee Osteoarthritis and Knee Joint Endoprosthesis Using an App · NA · recruiting
NCT06823271 — Haemodynamics and Ventricular Arrhythmias During Exercise in Patients With Arrhythmogenic Cardiomyopathy · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04680247 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Technical University of Munich
Last refreshed: 22 December 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04680247.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing